Abstract
Till now, the medicines approved for acute myeloid leukemia with internal tandem duplication mutation of FMS-like tyrosine kinase 3 (FLT3-ITD) dis-pla......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
